Skip to content

Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria

Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04501419
Enrollment
600
Registered
2020-08-06
Start date
2019-10-05
Completion date
2027-06-30
Last updated
2026-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Brief summary

The purpose of this study is to train Nigerian radiologists to perform ultrasound-guided breast biopsies on women that present to the hospital with a suspicious breast mass. Before performing biopsies on patients, the Nigerian radiologists will have already successfully completed a competency-based mobile health ultrasound-guided breast biopsy-training program. This program, developed by experts in Nigeria and the United States of America, certifies that they have the skills required to safely perform these biopsies on patients.

Interventions

PROCEDUREUS-guided breast biopsy

During this study, women with undergo an US-guided breast biopsy by a radiologist instead of what is typically performed in Nigerian hospitals, which is either a blind biopsy or surgical excision. US-guided breast biopsy is the standard of care in the United States of America because the accuracy is better than blind biopsy and equal to surgical excision.

OTHERUltrasound-guided breast biopsy training program

This program, developed by experts in Nigeria and the United States of America, certifies that they have the skills required to safely perform these biopsies on patients

Sponsors

Memorial Sloan Kettering Cancer Center
Lead SponsorOTHER
Obafemi Awolowo University Teaching Hospital
CollaboratorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age 18 and older female * Breast ultrasound demonstrating a solid mass that is suspicious for cancer, which would typically undergo either a blind biopsy or surgical excision at the Nigerian hospital where the patient is seeking diagnosis.

Exclusion criteria

* Participants unwilling to sign consent * Participants under the age of 18.

Design outcomes

Primary

MeasureTime frameDescription
Accuracy of US-guided breast biopsy in Nigeria compared to reference standard surgical excision12 monthsUS-guided breast biopsies accuracy measurements will be reported using surgical pathology as the reference standard. Specifically we will report accuracy, positive predictive value, negative predictive value, sensitivity and specificity.

Secondary

MeasureTime frameDescription
Complication rates from US-guided breast biopsy compared to reference values reported in the literature.12 monthsTo determine if the complication rate of US-guided breast biopsies performed by the trained Nigerian radiologists is equivalent to reference values reported in the literature.

Countries

Nigeria

Contacts

CONTACTAdeleye Omisore, MD
omisoreadeleye@yahoo.com+2348031538004
CONTACTElizabeth Sutton, MD
suttone@mskcc.org646-888-5455
PRINCIPAL_INVESTIGATORAdeleye Omisore, MD

Obafemi Awolowo University Teaching Hospitals

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 28, 2026